These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23686593)

  • 1. Compounding pharmacy oversight moves ahead.
    Traynor K
    Am J Health Syst Pharm; 2013 Jun; 70(11):920, 922, 924. PubMed ID: 23686593
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
    Williams KG
    J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 4. Compounding pharmacy industry has outgrown its regulatory system, ASHP and FDA say.
    Thompson CA
    Am J Health Syst Pharm; 2013 May; 70(9):747-8. PubMed ID: 23592352
    [No Abstract]   [Full Text] [Related]  

  • 5. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
    Blankenship C
    Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
    [No Abstract]   [Full Text] [Related]  

  • 6. International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Food and Drug Administration's Misguided Veterinary Guidance.
    Miller DG
    Int J Pharm Compd; 2015; 19(6):449-50. PubMed ID: 26891558
    [No Abstract]   [Full Text] [Related]  

  • 7. The Home Field Disadvantage.
    Cabaleiro J
    Int J Pharm Compd; 2016; 20(1):86-7. PubMed ID: 27125059
    [No Abstract]   [Full Text] [Related]  

  • 8. Compounding oversight a work in progress for states, FDA.
    Traynor K
    Am J Health Syst Pharm; 2016 Apr; 73(7):424-5. PubMed ID: 27001978
    [No Abstract]   [Full Text] [Related]  

  • 9. Judge allows bulk ingredients for compounding: ruling favors pharmacy, but FDA can still distinguish manufacturing, compounding.
    Cima G
    J Am Vet Med Assoc; 2011 Nov; 239(10):1266-68. PubMed ID: 22044321
    [No Abstract]   [Full Text] [Related]  

  • 10. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IACP's 2016 Compounders on Capitol Hill Asks.
    Int J Pharm Compd; 2016; 20(4):294-296. PubMed ID: 28333674
    [No Abstract]   [Full Text] [Related]  

  • 12. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
    Kastango ES; Bradshaw BD
    Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
    [No Abstract]   [Full Text] [Related]  

  • 13. President signs compounding law.
    Traynor K
    Am J Health Syst Pharm; 2014 Jan; 71(1):7. PubMed ID: 24352171
    [No Abstract]   [Full Text] [Related]  

  • 14. Final guidance for pharmacy compounding of human drug products under Section 503A.
    Blankenship CE
    Int J Pharm Compd; 2014; 18(5):379-80. PubMed ID: 25577886
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA, states discuss pharmacy compounding regulatory framework.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulators faulted for inadequate compounding pharmacy oversight.
    Traynor K
    Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of federal law to compounding of prescription orders.
    Breaux PJ
    J La State Med Soc; 1998 Jun; 150(6):275-8. PubMed ID: 9677787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compounding language drafted by congress.
    Nichols D
    J Nucl Med; 1997 Apr; 38(4):23N-24N. PubMed ID: 9098189
    [No Abstract]   [Full Text] [Related]  

  • 19. Discretion of the Food and Drug Administration to enforce compounding rules.
    Liu W; Knox CA; Brushwood DB
    Am J Health Syst Pharm; 2013 Sep; 70(17):1538-43. PubMed ID: 23943187
    [No Abstract]   [Full Text] [Related]  

  • 20. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.